Pure Global

Non-Alcoholic Fatty Liver Disease and Anthropometric Measurements - Trial NCT05810506

Access comprehensive clinical trial information for NCT05810506 through Pure Global AI's free database. This phase not specified trial is sponsored by Bandırma Onyedi Eylül University and is currently Completed. The study focuses on Non-Alcoholic Fatty Liver Disease. Target enrollment is 82 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05810506
Completed
other
Trial Details
ClinicalTrials.govNCT05810506
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Non-Alcoholic Fatty Liver Disease and Anthropometric Measurements
Evaluation of Anthropometric Measurements and Biochemical Parameters in Non-Alcoholic Fatty Liver Patients and Healthy Individuals

Study Focus

In the study, biochemical parameters will be taken from the anthropometric measurements and files of the patients without any intervention.

Observational

other

Sponsor & Location

Bandırma Onyedi Eylül University

Bandırma, Turkey

Timeline & Enrollment

N/A

Oct 01, 2021

Mar 17, 2023

82 participants

Primary Outcome

Body weight,Height,Body fat percentage,Neck circumference,Waist circumference,Hip circumference,Body mass index,Waist-to-length ratio,Waist to hip ratio,Body shape index,Body roundness index,Visceral adiposity index

Summary

The aim of this study; Which anthropometric measurement and ratio (BMI, waist circumference,
 hip circumference, waist-to-hip ratio, neck circumference, waist-height ratio, body shape
 index, body roundness index, visceral adiposity index) is a better indicator in healthy
 individuals with NAFLD and their biochemical parameters is to evaluate.

ICD-10 Classifications

Alcoholic fatty liver
Alcoholic liver disease, unspecified
Alcoholic liver disease
Liver disease, unspecified
Alcoholic cirrhosis of liver

Data Source

ClinicalTrials.gov

NCT05810506

Non-Device Trial